About PPD

PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations.

With offices in 45 countries and more than 11,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.

Laboratory Services

Applying scientific expertise for drug discovery as well as resources for early compound assessment and development

  • BioDuro, A PPD® Company
  • Nonclinical development
  • Preclinical services
  • Phase I clinic
  • GLP bioanalytical, cGMP product analysis, biomarker, vaccines and biologics, and Phase I-IV global central labs

Clinical Development Services

Providing comprehensive product development and post-approval services for biopharmaceuticals and devices

  • Full service Phase II-IIIb clinical studies for multinational regulatory submissions
  • Therapeutic and specialty expertise with dedicated project teams
  • Post-approval services, including epidemiology; pharmacoepidemiology and health outcomes; risk management and REMS; safety surveillance studies; late stage studies; medical information; product safety; registries; and observational studies
  • Clinical data management and information solutions, including consulting and proprietary software tools to speed collection, analysis and reporting of clinical data

 

 

 

Visit our Expert Community to learn about timely industry topics, get answers to your questions and learn from your peers.
PPD received the CEO Cancer Gold Standard™ accreditation from the CEO Roundtable on Cancer, recognizing the company's efforts to reduce cancer risks among employees and improve their overall health.
Learn about the CEO Roundtable on Cancer and the CEO Cancer Gold Standard™.